Similar Posts
Hydroxychloroquine (HCQ). Corrupt, coordinated assault managed by WHO on an inexpensive and effective treatment / Nass
I think most people have already figured out you can’t trust the mass media on the subject of the chloroquine drugs and Covid-19… let’s avoid the question of which subjects can they be trusted with? I thought you could trust medical journals to a degree, but even they, whose editors are physicians, have been…
Vaccine Healthcare Center physicians identify new muscle disease related to anthrax vaccinations
I discovered the following 3 year old conference presentation on the internet. Information on this syndrome has not been published in the medical literature, nor is information about it available on the VHC website. The recorded presentation is of great interest. Thursday, May 13, 2004 – 11:45 AM5034 Reproducible Prolonged Myalgia Syndrome (RPMS) Following Multiple…
Califf, Biden’s nominee for FDA Commish and currently a Google (Verily) employee w/many Pharma entanglements, wants the Acting crook Woodcock to stay on at FDA
Califf, nominee to lead FDA, asks Woodcock to stay in leadership role if he’s confirmed. By NICHOLAS FLORKO STEFANI REYNOLDS-POOL/GETTY IMAGES Rumors have swirled in Washington that Woodcock, a 35-year veteran of the FDA, would retire from the federal government. WASHINGTON — Robert Califf, President Biden’s pick to lead the Food and Drug Administration, has asked…
Evidence based medicine manifesto for better healthcare/ BMJ
Here is a very good start at diagnosing inherent problems in the medical research enterprise, and suggestions for correcting them.–Meryl BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2973 (Published 20 June 2017) Carl Heneghan, director1, Kamal R Mahtani, deputy director1, Ben Goldacre, director EBM DataLab1, Fiona Godlee, editor in chief2, Helen Macdonald, head of education2, Duncan Jarvies, multimedia editor2 A response to…
Pharmaceutical firm spied on top FDA official/ Politico and Mercola.com
From Politico, this story of how over $100,000 was spent to dig up dirt on the head of FDA’s Center for Drug Evaluation and Research: For more than two months in late 2008, private investigators working for a drug company gathered information on a high-ranking official at the Food and Drug Administration — unearthing details about…
Clinical trial data for all drugs in current use / BMJ
Re: Clinical trial data for all drugs in current use 31 October 2012 Dr. Godlee’s editorial (BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7304) underscores the importance of the GlaxoSmithKline decision to allow access to anonymized patient level data from its clinical trials. Meta-analysts can now work more efficiently in summarizing knowledge relating to the benefits and risks of…